NeurAxis (NASDAQ:NRXS – Get Free Report) and Medtronic (NYSE:MDT – Get Free Report) are both medical companies, but which is the superior stock? We will compare the two companies based on the strength ...

VMPL New Delhi [India] November 7 Medtronic a global leader in healthcare technology unveiled results from the Prospective ...

This growth is primarily driven by the rising prevalence of cardiovascular diseases (CVDs) worldwide, alongside continuous ...

Global Remote Patient Monitoring Market is estimated to be valued at $40B in 2023, expected to grow at CAGR of ~12% during the forecast period (2024 – 2030) ...

Here are five FDA alerts and recalls from 2024 for orthopedic and spine specialists to know: ...

The American Heart Association is highlighting the importance of continuous care for individuals with congenital heart ...

Boston Scientific is resuming its "Avant Guard" study of pulse field ablation (PFA) as a first-line therapy for atrial ...

Medtronic plc MDT is scheduled to report second-quarter fiscal 2025 results on Nov. 19, before the opening bell. In the last reported quarter, the company’s adjusted earnings of $1.23 exceeded the ...

Assistive Technology for Elder market is projected to grow from 12.5 Billion USD in 2024 to 25.0 Billion USD by 2032, at a CAGR of 7%.

England's NHS is testing an artificial pancreas for children with Type 1 diabetes, a device already available in India.

The pair has won several big cases for Masimo in the past two decades, collecting hundreds of millions of dollars in ...